Home › Osteosarcoom

Osteosarcoom klinische studies rekruteren in de VS

52 studies voor Osteosarcoom rekruteren deelnemers op locaties doorheen de Verenigde Staten.

Steden met de meeste studies

• Memphis, TN10 studies
• St. Louis, MO10 studies
• Atlanta, GA10 studies
• Boston, MA9 studies
• Mountain View, CA8 studies
• Birmingham, AL7 studies
• Houston, TX7 studies
• Chicago, IL7 studies
• Los Angeles, CA7 studies
• New York City, NY6 studies
• Tampa, FL6 studies
• Aurora, CO6 studies
• Washington, DC6 studies
• Philadelphia, PA6 studies
• Cincinnati, OH6 studies
• Honolulu, HI5 studies
• Dallas, TX5 studies
• Durham, NC5 studies
• The Bronx, NY5 studies
• Queens, NY4 studies
• Gainesville, FL4 studies
• Harrisburg, PA4 studies
• Orlando, FL4 studies
• Clifton, NJ4 studies
• San Francisco, CA4 studies
• Baltimore, MD4 studies
• Seattle, WA4 studies
• San Diego, CA4 studies
• Oakland, CA4 studies
• Columbus, OH4 studies
• Greenburgh, NY4 studies
• Salt Lake City, UT4 studies
• Cleveland, OH4 studies
• Edison, NJ3 studies
• Hartford, CT3 studies
• Miami, FL3 studies
• Nashville, TN3 studies
• Little Rock, AR3 studies
• Winston-Salem, NC3 studies
• Greenville, SC3 studies

Per staat

• Alabama7 studies
• Arizona5 studies
• Arkansas3 studies
• Californië18 studies
• Colorado6 studies
• Connecticut4 studies
• District of Columbia5 studies
• Florida10 studies
• Georgia10 studies
• Hawaï5 studies
• Illinois7 studies
• Louisiana3 studies
• Maryland5 studies
• Massachusetts9 studies
• Michigan6 studies
• Minnesota3 studies
• Missouri10 studies
• New Jersey6 studies
• New York11 studies
• North Carolina6 studies
• Ohio12 studies
• Oregon3 studies
• Pennsylvania9 studies
• Rhode Island3 studies
• South Carolina3 studies
• Tennessee12 studies
• Texas10 studies
• Utah4 studies
• Virginia3 studies
• Washington4 studies
• Wisconsin5 studies

Recent bijgewerkte studies

Officiële studietekst (Engels)

Van ClinicalTrials.gov, gegevens opgehaald op 2 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.